日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Vitamin A and its analogues modulate MUFAs metabolism to improve ferroptosis and aging by direct targeting of ACSL3

维生素A及其类似物通过直接靶向ACSL3来调节单不饱和脂肪酸(MUFA)代谢,从而改善铁死亡和衰老。

Luo, Nanxuan; Xiao, Yijie; Zhai, Yile; Li, Jie; Lv, Lijie; Yin, Houhua; Lin, Fang; Wan, Biwen; Zhang, Ke; Hu, Junchi; Liu, Junyan; Dang, Yongjun; He, Yi; Zhao, Yahui; Zhang, Zhe; Nie, Shenyou; Yuan, Hai-Xin

Genome-wide CRISPR screen identifies ACSL3 as a regulator of lipotoxicity and progression of MASLD

全基因组 CRISPR 筛选鉴定出 ACSL3 是脂毒性和 MASLD 进展的调节因子

Yuta Myojin,Takahiro Kodama,Ryo Takahashi,Hideharu Nagasawa,Yasuteru Kondo,Kosuke Yusa,Tomomi Yoshida-Hashidate,Hideo Shindou,Kunimaro Furuta,Kazuhiro Murai,Yoshinobu Saito,Hayato Hikita,Tetsuo Takehara

ACSL3 Promotes Hepatocellular Carcinoma Tumorigenesis and Correlates With JAK-STAT3 Signaling

ACSL3促进肝细胞癌的肿瘤发生,并与JAK-STAT3信号通路相关

Amelimojarad, Melika; Amelimojarad, Mandana; Pourmahdian, Alireza; Lu, Zhang

Modulating lipid metabolism by nanoparticles (NPs)-mediated ACSL3 silencing to inhibit hepatocellular carcinoma growth and metastasis

利用纳米颗粒(NPs)介导的ACSL3沉默调节脂质代谢,从而抑制肝细胞癌的生长和转移

Huang, Linzhuo; Xu, Rui; Chen, Siyu; Lin, Chunhao; Li, Wende; Li, Senlin; Saw, Phei Er; Zhang, Lei; Xu, Xiaoding

UCP2 Upregulates ACSL3 to Enhance Lipid Droplet Release from Acinar Cells and Modulates the Sirt1/Smad3 Pathway to Promote Macrophage-to-Myofibroblast Transition in Chronic Pancreatitis

UCP2上调ACSL3以增强腺泡细胞脂滴释放,并调节Sirt1/Smad3通路以促进慢性胰腺炎中巨噬细胞向肌成纤维细胞的转化

Wang, Kunpeng; Zhang, Lilong; Deng, Beiying; Jiang, Wanrong; Kuang, Tianrui; Chen, Chen; Zhao, Kailiang; Shi, Qiao; He, Jun; Wang, Weixing

Monounsaturated fatty acids promote cancer radioresistance by inhibiting ferroptosis through ACSL3

单不饱和脂肪酸通过ACSL3抑制铁死亡,从而促进癌症放射抗性。

Cao, Yulin; Li, Jiuming; Chen, Ying; Wang, Yuanben; Liu, Zhiang; Huang, Liuying; Liu, Bingxin; Feng, Yuyang; Yao, Surui; Zhou, Leyuan; Yin, Yuan; Huang, Zhaohui

Correction: Monounsaturated fatty acids promote cancer radioresistance by inhibiting ferroptosis through ACSL3

更正:单不饱和脂肪酸通过ACSL3抑制铁死亡,从而促进癌症放射抗性。

Cao, Yulin; Li, Jiuming; Chen, Ying; Wang, Yuanben; Liu, Zhiang; Huang, Liuying; Liu, Bingxin; Feng, Yuyang; Yao, Surui; Zhou, Leyuan; Yin, Yuan; Huang, Zhaohui

Commentary: Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCC

评论:转录因子MEF2D通过抑制铁死亡调控ACSL3的异常表达,增强肝细胞癌的索拉非尼耐药性。

Chen, Xiaoyan; Xie, Jin; Fan, Wei; Zhang, Junfeng; Gao, Feng; Li, Zhi

Lipid Metabolism Related Gene ACSL3 as a Biomarker for Predicting Immunotherapy Outcomes in Lung Adenocarcinoma

脂质代谢相关基因ACSL3作为预测肺腺癌免疫治疗疗效的生物标志物

He, Taiping; Hu, Jinhan; Guo, Haoyue; Diao, Meng; Wang, Yuanyuan; Wu, Yuhan; Cheng, Lei; Zhao, Chao; Li, Xuefei; Zhou, Caicun

Multidimensional analysis reveals the potential of ACSL3 as a cancer biomarker: from pan-cancer exploration to functional validation in hepatocellular carcinoma

多维分析揭示了ACSL3作为癌症生物标志物的潜力:从泛癌探索到肝细胞癌的功能验证

Niu, Qun; Mou, Yu; Yao, Yuanqian; Dong, HaiJian; Wang, Kaixin; Zeng, Zijian; Tao, Yujing; Gong, Xueqing; Li, Hui